Grace Therapeutics, Inc.

DB:L8S Stock Report

Market Cap: €29.2m

Grace Therapeutics, Inc. Company Information

Grace Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Grace Therapeutics, Inc.
  • Ticker: L8S
  • Exchange: DB
  • Founded: 2002
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$31.788m
  • Listing Market Cap: US$29.166m
  • Shares Outstanding: 10.14m
  • Website: https://www.acastipharma.com

Number of Employees

Location

  • Grace Therapeutics, Inc.
  • 103 Carnegie Center
  • Suite 300
  • Princeton
  • New Jersey
  • 08540
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GRCENasdaqCM (Nasdaq Capital Market)YesClass A SharesUSUSDMar 2011
L8SDB (Deutsche Boerse AG)YesClass A SharesDEEURMar 2011

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/05 19:26
End of Day Share Price 2024/10/07 00:00
Earnings2024/06/30
Annual Earnings2024/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.